Comparative Prognostic Assessment of EKFC Equations for Mortality Prediction: A Population-based Cohort Study [0.03%]
基于人群的队列研究中EKFC方程组预测死亡率的比较评估
Sitong Chen,Jinjing Shi,Iokfai Cheang et al.
Sitong Chen et al.
Background: The European Kidney Function Consortium (EKFC) has introduced equations for estimating glomerular filtration rate (eGFR) using serum creatinine (Cr) and cystatin C (Cys). While their diagnostic accuracy is est...
Divergent Role of Statin Use and Intensity in Patients Undergoing Transcatheter Aortic Valve Replacement [0.03%]
他莫昔芬在经导管主动脉瓣置换术患者中的应用作用及强度的分化作用
Haitham Abu Khadija,Alena Kirzhner,Nizar Abu Hamdeh et al.
Haitham Abu Khadija et al.
Aims: Acute kidney injury (AKI) and reduced glomerular filtration rate (GFR) frequently complicate transcatheter aortic valve replacement (TAVR). We aimed to assess the impact of preprocedural statin use and intensity on ...
Estimated Plasma Volume Status May Modify the Association Between Estimated Glomerular Filtration Rate and Atrial Fibrillation in HFpEF: A Post Hoc Analysis of the TOPCAT Trial [0.03%]
估计血浆容量状态可能会修改HFpEF患者中估计肾小球滤过率与房颤之间的关联：来自TOPCAT试验的事后分析结果
Jialing Zhang,Qing Wang
Jialing Zhang
Background: This post hoc analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial examined whether estimated plasma volume status (ePVS) modifies the association...
Renal Replacement Therapy in CKM: Challenges for Dialytic Therapies and Kidney Transplantation [0.03%]
慢性肾脏病透析治疗的挑战与肾移植疗法闪烁曙光
Mahtab Mashayekhi,Jasjot Bhullar,Zohreh Gholizadeh Ghozloujeh et al.
Mahtab Mashayekhi et al.
Cardiovascular-kidney-metabolic (CKM) syndrome integrates the strong interrelationship among cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic risk factors such as obesity and diabetes. Renal replacement therapy (RRT...
Tubular biomarkers N-acetyl-ß-D-glucosaminidase, kidney-injury-molecule 1 and Neutrophil gelatinase-associated lipocalin: long term follow-up in a chest pain cohort [0.03%]
管型生物标志物N-乙酰-β-D-岩藻糖甘露糖苷酶、肾损伤分子-1和中性粒细胞明胶酶相关脂质运载蛋白：一项关于胸痛患者的长期随访研究
Andreas Leonhard Schober,Julia Bindig,Michael Philipp Schober et al.
Andreas Leonhard Schober et al.
Introduction The goal of the current study was to evaluate the prognostic value of the potential cardiorenal biomarkers kidney injury molecule-1 (u-KIM-1), N-acteyl-ß-D-glucosaminidase (NAG) and urinary Neutrophil gelatinase-associated lip...
Potential mechanisms of sodium-glucose cotransporter 2 inhibitors in regulating cardiac and renal fibrosis [0.03%]
钠葡萄糖协同转运蛋白2抑制剂调节心脏和肾脏纤维化的潜在机制
Wei Huang,Tianxiang Guan,Ziyou Yan et al.
Wei Huang et al.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors represent a novel class of therapeutic agents for treating diabetic kidney disease. These drugs primarily act by inhibiting the reabsorption of sodium and glucose in the renal proximal tubul...
Preventing Cardiovascular-Kidney-Metabolic (CKM) Syndrome Progression: Pharmacologic Approaches and Pharmacists' Contributions [0.03%]
预防心血管-肾脏-代谢（CKM）综合征进展：药物治疗和药师的贡献
Theresa Nguyen,Lisa Hong,Tomona Iso
Theresa Nguyen
Background Cardiovascular-kidney-metabolic (CKM) syndrome is a condition reflecting the interactions among metabolic dysfunction, chronic kidney disease (CKD), and cardiovascular disease. It is driven by excess adipose tissue, insulin resis...
In the article "Denosumab Decreases Epicardial Adipose Tissue Attenuation in Dialysis Patients with Secondary Hyperparathyroidism and Low Bone Mass" [Cardiorenal Med. 2024;14(1):113-122; https://doi.org/10.1159/000535882], the authors ident...
Published Erratum
Cardiorenal medicine. 2026;16(1):153. DOI:10.1159/000551758 2026
Chronic Kidney Disease, Circulating Ceramides and Coronary Microvascular Dysfunction: Insights from the CRUISE-MET Study [0.03%]
慢性肾脏病、循环鞘氨醇和冠状微血管功能障碍：来自CRUISE-MET研究的启示
Qiang Chen,Xuexi Li,Yingying Xie et al.
Qiang Chen et al.
Background: Ceramides and chronic kidney disease (CKD) independently associate with coronary microvascular dysfunction (CMD), but their combined association remains unestablished, warranting investigation. ...
Review of Hyperkalemia Profile for Mineralocorticoid Receptor Antagonist in Patients with Chronic Kidney Disease and Type 2 Diabetes [0.03%]
回顾性分析肾病及糖尿病患者使用盐皮质激素受体拮抗剂的高钾血症谱系风险
Jessica B Kendrick,Angelina Magreni Dixon
Jessica B Kendrick
Background: Type 2 diabetes (T2D) frequently coexists with chronic kidney disease (CKD), magnifying the risk of both cardiovascular and renal complications. Although therapies targeting the renin-angiotensin-aldosterone s...